Parabilis Medicines 1 article

Within molecular therapeutics, Parabilis Medicines operates as a peptide-therapeutics biotechnology company built around constrained peptide therapeutics and Helicon alpha-helical peptide platform. Its design strategy also includes intracellular protein target engagement and cell-permeable peptide design, with AI-guided peptide discovery defining a key receptor, delivery or structural feature of the peptide modality. Specific peptide scaffolds and therapeutic products remain distinct tags; the peptide platform of Parabilis Medicines also includes difficult-to-drug intracellular targets.